Found 218 matching trials
Node-sparing Short-Course Radiation Combined With CAPOX and Tislelizumab for MSS Rectal Cancer PHASE3 This is a randomized, prospective, multicenter, open-label, Phase III clini...
Show More Status
Active Not Recruiting
Location
Sir Run Run Shao hospital
Learn More & Join Trial
Radiotherapy Plus Iparomlimab and Tuvonralimab (QL1706), Regorafenib, and CAPOX as Neoadjuvant Therapy for pMMR/MSS LARC. PHASE2 This study is a multicenter, prospective, randomized, double-arm, Phase II ...
Show More Location
Dept. of Colorectal Surgery, Sun Yat-sen University Cancer Center. Yuexiu District, Dongfeng East Road 651
Learn More & Join Trial
KORTUC (KRC-01) Plus Radiotherapy for Organ Preservation in Rectal Cancer PHASE2 This phase II clinical trial is evaluating whether adding KRC-01 injections...
Show More Learn More & Join Trial
Short Course Radiotherapy Followed by CAPOX and Carrilizumab and Bevacizumab or Cetuximab for the Initial Treatment of Unresectable Metastatic Rectal Cancer PHASE2 To evaluate the efficacy and safety of short-course radiotherapy followed b...
Show More Location
Multiple Locations
Learn More & Join Trial
Short-Course Radiotherapy Followed by Neoadjuvant Chemotherapy and Camrelizumab in Locally Advanced Rectal Cancer (UNION) PHASE3 The study is a multicenter, open-label, randomized controlled clinical stud...
Show More Status
Active Not Recruiting
Location
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Learn More & Join Trial
Neoadjuvant CAPEOX Versus Upfront Surgery for Locally Advanced Colon Cancer With Elevated CEA: A Single-Center, Open-Label, Randomized Controlled Trial NA The goal of this interventional clinical trial is to compare the efficacy o...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study Comparing Adjuvant Chemotherapy Versus Observation for Patients With Rectal Adenocarcinoma After Neoadjuvant Chemo-Radiotherapy Treatment. PHASE3 Surgery is the most indicated curative treatment for rectal cancer when dis...
Show More Learn More & Join Trial
Timing of Minimally Invasive Local Treatment After First-Line Systemic Therapy in Oligometastatic Esophageal or Gastric Adenocarcinoma PHASE2 Purpose of the Study:
This clinical study investigates whether a shorter o...
Show More Location
Amsterdam University Medical Center
Learn More & Join Trial
Anti-PCSK9 Antibody Tafolecimab and Anti-PD-1 Antibody Sintilimab Combined With Neoadjuvant Chemoradiotherapy for pMMR/ MSS Locally Advanced Rectal Cancer : A Prospective, Multicenter, Randomized, Open-Label, Parallel-Controlled Trial PHASE3 This is a randomized, controlled clinical trial based on prior exploratory ...
Show More Location
Guangdong Provincial People's Hospital
Learn More & Join Trial
Assess the Efficacy of Radiotherapy and Sequential Chemotherapy and AK104 Before TME Surgery for Local CRC(AK104-IIT-13) PHASE2 This study is a single-arm, open-label, multicenter clinical study to evalu...
Show More Location
Multiple Locations
Learn More & Join Trial